Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor site maintenance update with no changes to study data or content.
    Difference
    0.0%
    Check dated 2026-03-11T20:15:57.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 and removes the earlier government-funding notices and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:50:02.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH Clinical Center status. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T00:25:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle, and updates to labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision note to v3.4.0, which are formatting and metadata changes rather than changes to the study details themselves. There are no changes to core study content, eligibility, endpoints, or primary conclusions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T00:32:55.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive study details appear to be affected.
    Difference
    0.0%
    Check dated 2026-01-14T01:37:40.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations were updated with new sites across multiple U.S. states and international regions (Australia, United Kingdom, Canada), and several previously listed locations were removed. This update changes the geographic footprint of the trial.
    Difference
    2%
    Check dated 2025-12-23T17:21:28.000Z thumbnail image

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.